ArticlePhysiological reports2026
Are saliva and bile sources of oxalate secretion into the human gastrointestinal tract?
Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Elevated urine oxalate (hyperoxaluria) is a risk factor for kidney stones. Normally eliminated by the kidneys, oxalate originates from endogenous metabolism and dietary absorption but secretion into the intestine remains an open question. We considered saliva and bile as two potential sources. Previous studies report ≥100 μmol/L oxalate in saliva, far exceeding blood (1-3 μmol/L), implying secretion. With the liver being the main site of oxalate synthesis, bile is another path into the intestine. We set out to (1) Verify these salivary oxalate concentrations and rates of secretion. (2) Measure oxalate concentrations in bile. Saliva was obtained from healthy volunteers and bile from patients undergoing endoscopic retrograde cholangiopancreatography. Oxalate was determined by commercial assay and ion chromatography coupled with mass spectrometry (IC-MS). With the assay, salivary oxalate averaged 21 μmol/L. However, using IC-MS, values were ~1 μmol/L, comparable to plasma. This disparity resulted from positive interference with the enzyme-based assay by one or more constituents in saliva. The rate of salivary secretion thus proved negligible. Bile oxalate averaged 14 μmol/L, suggesting hepatocyte secretion but biliary clearance is minor (<5%), relative to urine. We conclude saliva and bile are insignificant sources of secretion and unnecessary for determining oxalate clearance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.